Evidence map›Paper›PMID 30045711›Full record

ArticleBMC public health2018

Evaluating the impact of the DREAMS partnership to reduce HIV incidence among adolescent girls and young women in four settings: a study protocol.

Isolde Birdthistle, Susan B Schaffnit, Daniel Kwaro, Maryam Shahmanesh, Abdhalah Ziraba, Caroline W Kabiru, Penelope Phillips-Howard, Natsayi Chimbindi, Kenneth Ondeng'e, Annabelle Gourlay and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 4 pooled it
34.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 4 syntheses or guidelines pooled it, 134 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 5 countries.

Isolde BirdthistleFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. Isolde.Birdthistle@lshtm.ac.uk.ORCID 0000-0001-5742-6588
Susan B SchaffnitFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Daniel KwaroCentre for Global Health Research, Kenyan Medical Research Institute, Kisumu, 40100, Kenya.
Maryam ShahmaneshInstitute for Global Health, University College of London, Capper St, London, WC1E 6JB, UK.
Abdhalah ZirabaAfrican Population and Health Research Center, Manga Close off Kirawa Road, Nairobi, Kenya.
Caroline W KabiruAfrican Population and Health Research Center, Manga Close off Kirawa Road, Nairobi, Kenya.
Penelope Phillips-HowardDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
Natsayi ChimbindiAfrica Health Research Institute, 719 Umbilo Road, Durban, KwaZulu-Natal, 4001, South Africa.
Kenneth Ondeng'eCentre for Global Health Research, Kenyan Medical Research Institute, Kisumu, 40100, Kenya.
Annabelle GourlayFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Frances M CowanDepartment of International Public Health, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, Zimbabwe.
James R HargreavesFaculty of Public Health & Policy, London School of Hygiene & Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK.
Bernadette HensenFaculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Tarisai ChiyakaCentre for Sexual Health and HIV/AIDS Research (CeSHHAR), 9 Monmouth Road, Avondale West Harare, Zimbabwe.
Judith R GlynnFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Sian FloydFaculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
University of London · GBAfrica Health Research Institute · ZAAfrican Population and Health Research Center · KEKenya Medical Research Institute · KECentre for Sexual Health and HIV AIDS Research · ZWLiverpool School of Tropical Medicine · GBLondon School of Hygiene & Tropical Medicine · GBUniversity of Zimbabwe · ZW

Funding

Maximizing combination HIV prevention, uptake and retention by adolescent girls and young womenR01MH114560 · NIMH · KWAZULU-NATAL RESEARCH INSTITUTE TB-HIV · PI SHAHMANESH, MARYAM · 2017 to 2023
$2.0M
Medical Research Council MR/K012126/1NIMH NIH HHS R01 MH114560
6 · The paper itself

Abstract

backgroundHIV risk remains unacceptably high among adolescent girls and young women (AGYW) in southern and eastern Africa, reflecting structural and social inequities that drive new infections. In 2015, PEPFAR (the United States President's Emergency Plan for AIDS Relief) with private-sector partners launched the DREAMS Partnership, an ambitious package of interventions in 10 sub-Saharan African countries. DREAMS aims to reduce HIV incidence by 40% among AGYW over two years by addressing multiple causes of AGYW vulnerability. This protocol outlines an impact evaluation of DREAMS in four settings.

methodsTo achieve an impact evaluation that is credible and timely, we describe a mix of methods that build on longitudinal data available in existing surveillance sites prior to DREAMS roll-out. In three long-running surveillance sites (in rural and urban Kenya and rural South Africa), the evaluation will measure: (1) population-level changes over time in HIV incidence and socio-economic, behavioural and health outcomes among AGYW and young men (before, during, after DREAMS); and (2) causal pathways linking uptake of DREAMS interventions to 'mediators' of change such as empowerment, through to behavioural and health outcomes, using nested cohort studies with samples of ~ 1000-1500 AGYW selected randomly from the general population and followed for two years. In Zimbabwe, where DREAMS includes an offer of pre-exposure HIV prophylaxis (PrEP), cohorts of young women who sell sex will be followed for two years to measure the impact of 'DREAMS+PrEP' on HIV incidence among young women at highest risk of HIV. In all four settings, process evaluation and qualitative studies will monitor the delivery and context of DREAMS implementation. The primary evaluation outcome is HIV incidence, and secondary outcomes include indicators of sexual behavior change, and social and biological protection. DISCUSSION: DREAMS is, to date, the most ambitious effort to scale-up combinations or 'packages' of multi-sectoral interventions for HIV prevention. Evidence of its effectiveness in reducing HIV incidence among AGYW, and demonstrating which aspects of the lives of AGYW were changed, will offer valuable lessons for replication.

Indexed as

AdolescentAdultChildCohort StudiesEpidemiologic Research DesignFemaleHIVHIV InfectionsHumansIncidenceKenyaLongitudinal StudiesPopulation SurveillancePre-Exposure ProphylaxisPregnancyProgram EvaluationAdolescent healthComplex interventionGender equityHIV preventionImpact evaluationKenyaSouth AfricaZimbabwe

Identifiers

PMID30045711
PMCPMC6060450
OpenAlexW2884060707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.